Home/Filings/4/0001654954-24-000295
4//SEC Filing

Nardo Christopher J. 4

Accession 0001654954-24-000295

CIK 0001853816other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 9:01 PM ET

Size

5.4 KB

Accession

0001654954-24-000295

Insider Transaction Report

Form 4
Period: 2024-01-04
Nardo Christopher J.
Senior VP, CDO
Transactions
  • Award

    Stock Option (right to buy

    2024-01-04+50,00050,000 total
    Exercise: $0.61Exp: 2034-01-03Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Issuer

Dermata Therapeutics, Inc.

CIK 0001853816

Entity typeother

Related Parties

1
  • filerCIK 0001870247

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:01 PM ET
Size
5.4 KB